FDA
The latest news on FDA
Jun 2, 2013
Lambrolizumab activates body's immune system to kill cancerous cells, researchers say
May 29, 2013
This cancer is leading cause of death from skin disease
May 29, 2013
Ingredients for intravenous feeding in short supply after company closure, FDA says
May 29, 2013
Memory chips help prevent release of unwanted products
May 23, 2013
Initial study suggested a cancer drug could reverse effects of Alzheimer's in mice.
May 20, 2013
New survey finds 1 in 7 products still claim an 'SPF' rating of 50 or higher
May 16, 2013
When disease has spread to the bones
May 16, 2013
Gene present in 10 percent of NSCLC cases
May 15, 2013
Blocks process that contributes to abnormal inflammation
May 15, 2013
Xofigo was fast-tracked for approval and is meant for tumors that have spread to the bones
